SCHEMBL3010460

SCHEMBL3010460

COc1ccc2[nH]cc(/C=C/[N+](=O)[O-])c2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.63
CYP1A2 P05177 1/20 0.63
CYP2C19 P33261 1/20 0.63
MTNR1A P48039 1/20 0.58
MTNR1B P49286 1/20 0.58
MAPT P10636 5/20 0.56
MEN1 O00255 3/20 0.56
RAB9A P51151 3/20 0.56
KMT2A Q03164 3/20 0.56
NPC1 O15118 1/20 0.56
MAOA P21397 1/20 0.54
MAOB P27338 1/20 0.54
FBP1 P09467 2/20 0.50
GAA P10253 1/20 0.49
KDM4E B2RXH2 2/20 0.49
GPR84 Q9NQS5 1/20 0.48
NTRK1 P04629 2/20 0.47
PRKD3 O94806 1/20 0.47
ABL1 P00519 1/20 0.47
RET P07949 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3010462 1.00 ALDH1A1 (0.63) ALDH1A1CYP1A2CYP2C19MTNR1AMTNR1B
SCHEMBL2536634 0.89 MAPT (0.63) ALDH1A1CYP1A2CYP2C19MTNR1AMTNR1B
SCHEMBL2536633 0.89 MAPT (0.63) ALDH1A1CYP1A2CYP2C19MTNR1AMTNR1B
SCHEMBL29637948 0.89 MAPT (0.63) ALDH1A1CYP1A2CYP2C19MTNR1AMTNR1B
SCHEMBL17490947 0.85 TLR4 (0.55) ALDH1A1CYP1A2CYP2C19MTNR1AMTNR1B
SCHEMBL2537801 0.83 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP2C19MTNR1AMTNR1B
SCHEMBL2537799 0.83 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP2C19MTNR1AMTNR1B
SCHEMBL17488523 0.82 MEN1 (0.52) ALDH1A1CYP1A2CYP2C19MTNR1AMTNR1B
SCHEMBL8404322 0.82 MEN1 (0.52) ALDH1A1CYP1A2CYP2C19MTNR1AMTNR1B
SCHEMBL13947142 0.80 ALDH1A1 (0.69) ALDH1A1CYP1A2CYP2C19MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114680114-B Application of melatonin derivative in preventing and treating plant fungal diseases 华中农业大学 2022-11-15 CN disclosed
CN-114680114-A Application of melatonin derivative in preventing and treating plant fungal diseases 华中农业大学 2022-07-01 CN disclosed
US-8258173-B2 Melatonin derivatives and their use as antioxidants UNIVERSITY OF SUNDERLAND (GB) 2012-09-04 US disclosed
US-20100204276-A1 INDOLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2010-08-12 US disclosed
US-20100063125-A1 MELATONIN DERIVATIVES AND THEIR USE AS ANTIOXIDANTS UNIVERSITY OF SUNDERLAND (GB) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063125-A1 MELATONIN DERIVATIVES AND THEIR USE AS ANTIOXIDANTS MTNR1A, MTNR1B, TXNRD2 ALDH1A1 250/4885CYP1A2 217/4885CYP2C19 419/4885
US-20100204276-A1 INDOLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM MTNR1A, MTNR1B, IDO1 ALDH1A1 727/4885CYP1A2 73/4885CYP2C19 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.